GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hofseth BioCare ASA (FRA:HBQ) » Definitions » Operating Cash Flow per Share

Hofseth BioCare ASA (FRA:HBQ) Operating Cash Flow per Share : €-0.01 (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Hofseth BioCare ASA Operating Cash Flow per Share?

Hofseth BioCare ASA's operating cash flow per share for the three months ended in Mar. 2025 was €-0.00. Hofseth BioCare ASA's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 48.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Hofseth BioCare ASA's Operating Cash Flow per Share or its related term are showing as below:

FRA:HBQ' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -32.9   Med: -6.2   Max: 48.2
Current: 48.2

During the past 13 years, Hofseth BioCare ASA's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.20% per year. The lowest was -32.90% per year. And the median was -6.20% per year.

FRA:HBQ's 3-Year OCF Growth Rate is ranked better than
85.16% of 1429 companies
in the Consumer Packaged Goods industry
Industry Median: 8.3 vs FRA:HBQ: 48.20

Hofseth BioCare ASA Operating Cash Flow per Share Historical Data

The historical data trend for Hofseth BioCare ASA's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA Operating Cash Flow per Share Chart

Hofseth BioCare ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.02 -0.01 - -

Hofseth BioCare ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.01 - -

Competitive Comparison of Hofseth BioCare ASA's Operating Cash Flow per Share

For the Packaged Foods subindustry, Hofseth BioCare ASA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hofseth BioCare ASA's Price-to-Operating-Cash-Flow Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hofseth BioCare ASA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hofseth BioCare ASA's Price-to-Operating-Cash-Flow falls into.


;
;

Hofseth BioCare ASA Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Hofseth BioCare ASA's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=-0.832/410.906
=-0.00

Hofseth BioCare ASA's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )=Cash Flow from Operations (Q: Mar. 2025 )/Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
=-1.148/412.081
=-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hofseth BioCare ASA Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hofseth BioCare ASA Business Description

Traded in Other Exchanges
Address
Keiser Wilhelms Gate 24, Aalesund, NOR, 6003
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its products and their respective brands include salmon oil (OmeGo), hydrolyzed soluble protein (ProGo), Calcium/Collagen (CalGo or NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. It generates maximum revenue from the sale of salmon oil. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.

Hofseth BioCare ASA Headlines

No Headlines